Paul Rozance
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 74 | 2025 | 864 | 7.630 |
Why?
| | Hypoglycemia | 29 | 2024 | 460 | 7.100 |
Why?
| | Glucose | 47 | 2024 | 1032 | 7.020 |
Why?
| | Fetus | 47 | 2025 | 799 | 6.870 |
Why?
| | Fetal Growth Retardation | 54 | 2024 | 558 | 6.780 |
Why?
| | Insulin | 45 | 2025 | 2448 | 5.180 |
Why?
| | Placental Insufficiency | 21 | 2024 | 115 | 4.850 |
Why?
| | Amino Acids | 20 | 2025 | 496 | 3.640 |
Why?
| | Blood Glucose | 34 | 2025 | 2239 | 3.610 |
Why?
| | Islets of Langerhans | 13 | 2024 | 792 | 3.440 |
Why?
| | Insulin-Secreting Cells | 14 | 2024 | 375 | 3.350 |
Why?
| | Pregnancy | 89 | 2025 | 6829 | 3.000 |
Why?
| | Insulin-Like Growth Factor I | 9 | 2024 | 325 | 2.970 |
Why?
| | Placenta | 16 | 2025 | 753 | 2.790 |
Why?
| | Glucagon | 10 | 2025 | 104 | 2.670 |
Why?
| | Liver | 20 | 2025 | 1805 | 2.500 |
Why?
| | Fetal Development | 17 | 2024 | 297 | 2.430 |
Why?
| | Pancreas | 14 | 2024 | 322 | 2.220 |
Why?
| | Hyperinsulinism | 7 | 2020 | 122 | 2.040 |
Why?
| | Leucine | 8 | 2022 | 116 | 1.980 |
Why?
| | Hyperglycemia | 7 | 2021 | 358 | 1.890 |
Why?
| | Infant, Premature | 8 | 2024 | 578 | 1.710 |
Why?
| | Infant, Newborn, Diseases | 5 | 2019 | 113 | 1.700 |
Why?
| | Maternal-Fetal Exchange | 7 | 2024 | 167 | 1.530 |
Why?
| | Animals | 87 | 2025 | 37217 | 1.470 |
Why?
| | Fetal Blood | 10 | 2024 | 336 | 1.330 |
Why?
| | Muscle, Skeletal | 15 | 2022 | 1729 | 1.300 |
Why?
| | Myoblasts | 3 | 2021 | 81 | 1.280 |
Why?
| | Infant, Newborn | 25 | 2024 | 6144 | 1.240 |
Why?
| | Female | 100 | 2025 | 73763 | 1.210 |
Why?
| | Monitoring, Physiologic | 3 | 2018 | 279 | 1.150 |
Why?
| | Cell Proliferation | 6 | 2024 | 2480 | 1.140 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2024 | 258 | 1.140 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 55 | 1.140 |
Why?
| | Hypoxia | 6 | 2021 | 1149 | 1.130 |
Why?
| | Gestational Age | 14 | 2021 | 916 | 1.090 |
Why?
| | Gluconeogenesis | 8 | 2025 | 78 | 0.980 |
Why?
| | Placental Lactogen | 6 | 2024 | 23 | 0.970 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 23 | 0.960 |
Why?
| | Hepatocyte Growth Factor | 2 | 2016 | 35 | 0.930 |
Why?
| | Metformin | 2 | 2024 | 331 | 0.810 |
Why?
| | Hypoglycemic Agents | 7 | 2024 | 1341 | 0.800 |
Why?
| | Diabetes, Gestational | 3 | 2022 | 319 | 0.760 |
Why?
| | Hindlimb | 3 | 2021 | 133 | 0.730 |
Why?
| | Streptozocin | 1 | 2021 | 23 | 0.700 |
Why?
| | Muscle Proteins | 3 | 2022 | 239 | 0.690 |
Why?
| | Signal Transduction | 9 | 2021 | 5086 | 0.690 |
Why?
| | NF-kappa B | 2 | 2021 | 678 | 0.660 |
Why?
| | Caloric Restriction | 2 | 2024 | 124 | 0.640 |
Why?
| | Oxygen | 13 | 2024 | 977 | 0.610 |
Why?
| | RNA Interference | 5 | 2024 | 468 | 0.600 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 70 | 0.570 |
Why?
| | Anemia | 2 | 2017 | 175 | 0.550 |
Why?
| | Catecholamines | 2 | 2017 | 91 | 0.540 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2016 | 30 | 0.530 |
Why?
| | Surface-Active Agents | 1 | 2017 | 92 | 0.520 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.500 |
Why?
| | Respiratory System | 1 | 2017 | 157 | 0.490 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 434 | 0.480 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2016 | 54 | 0.480 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 768 | 0.480 |
Why?
| | Developmental Disabilities | 2 | 2015 | 268 | 0.480 |
Why?
| | Oxidation-Reduction | 8 | 2024 | 1076 | 0.480 |
Why?
| | RNA, Messenger | 7 | 2022 | 2815 | 0.470 |
Why?
| | Sweetening Agents | 1 | 2015 | 54 | 0.470 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2016 | 549 | 0.470 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2021 | 684 | 0.470 |
Why?
| | Lactic Acid | 8 | 2024 | 303 | 0.460 |
Why?
| | Postpartum Period | 1 | 2018 | 345 | 0.460 |
Why?
| | Infant, Small for Gestational Age | 2 | 2018 | 92 | 0.460 |
Why?
| | Diazoxide | 3 | 2024 | 21 | 0.450 |
Why?
| | Humans | 45 | 2024 | 138651 | 0.430 |
Why?
| | Disease Models, Animal | 15 | 2024 | 4315 | 0.430 |
Why?
| | Uterus | 5 | 2022 | 219 | 0.430 |
Why?
| | Acidosis | 2 | 2020 | 102 | 0.430 |
Why?
| | Pregnancy Complications | 3 | 2019 | 535 | 0.420 |
Why?
| | Placental Circulation | 3 | 2021 | 71 | 0.410 |
Why?
| | Endothelial Cells | 3 | 2018 | 791 | 0.410 |
Why?
| | Hepatocytes | 5 | 2024 | 211 | 0.380 |
Why?
| | Periodicals as Topic | 2 | 2017 | 212 | 0.380 |
Why?
| | Stress, Physiological | 1 | 2016 | 450 | 0.380 |
Why?
| | Glucose Clamp Technique | 5 | 2020 | 196 | 0.380 |
Why?
| | Organ Size | 7 | 2021 | 471 | 0.370 |
Why?
| | Random Allocation | 7 | 2012 | 363 | 0.370 |
Why?
| | Muscle Development | 3 | 2021 | 114 | 0.360 |
Why?
| | Malnutrition | 1 | 2012 | 82 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2024 | 2490 | 0.340 |
Why?
| | Male | 27 | 2024 | 68260 | 0.330 |
Why?
| | Pulmonary Artery | 2 | 2018 | 1109 | 0.320 |
Why?
| | Dietary Supplements | 3 | 2012 | 553 | 0.320 |
Why?
| | Insulins | 2 | 2022 | 37 | 0.320 |
Why?
| | Dietary Proteins | 1 | 2011 | 135 | 0.310 |
Why?
| | Insulin Resistance | 7 | 2019 | 1222 | 0.300 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 14 | 0.300 |
Why?
| | Pulmonary Alveoli | 1 | 2011 | 408 | 0.290 |
Why?
| | Infant | 9 | 2023 | 9574 | 0.280 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 145 | 0.280 |
Why?
| | Fetal Diseases | 3 | 2021 | 177 | 0.270 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 216 | 0.270 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2590 | 0.270 |
Why?
| | Infusion Pumps | 2 | 2021 | 33 | 0.250 |
Why?
| | Down-Regulation | 3 | 2017 | 635 | 0.250 |
Why?
| | Fetal Macrosomia | 2 | 2021 | 62 | 0.250 |
Why?
| | Amino Acids, Essential | 1 | 2006 | 13 | 0.250 |
Why?
| | Up-Regulation | 4 | 2017 | 851 | 0.250 |
Why?
| | History, 20th Century | 3 | 2017 | 323 | 0.240 |
Why?
| | Glucose-6-Phosphatase | 4 | 2016 | 33 | 0.240 |
Why?
| | Infusions, Intravenous | 5 | 2024 | 411 | 0.230 |
Why?
| | Breast Feeding | 2 | 2019 | 422 | 0.230 |
Why?
| | Sheep, Domestic | 6 | 2019 | 34 | 0.230 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 26 | 0.230 |
Why?
| | Pediatrics | 5 | 2018 | 1078 | 0.220 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2024 | 611 | 0.220 |
Why?
| | Neonatologists | 1 | 2024 | 7 | 0.220 |
Why?
| | Fetal Heart | 1 | 2024 | 56 | 0.210 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 101 | 0.200 |
Why?
| | Norepinephrine | 4 | 2020 | 192 | 0.200 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 548 | 0.200 |
Why?
| | Lipid Metabolism | 3 | 2024 | 522 | 0.200 |
Why?
| | Arginine | 4 | 2012 | 261 | 0.200 |
Why?
| | Nervous System Diseases | 1 | 2006 | 273 | 0.200 |
Why?
| | Chronic Disease | 4 | 2017 | 1805 | 0.200 |
Why?
| | Hydrocortisone | 5 | 2020 | 314 | 0.200 |
Why?
| | Carbohydrates | 1 | 2022 | 67 | 0.190 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2020 | 22 | 0.190 |
Why?
| | Fetal Weight | 3 | 2022 | 55 | 0.180 |
Why?
| | Glycogen | 3 | 2020 | 52 | 0.180 |
Why?
| | Diet, High-Fat | 2 | 2023 | 247 | 0.180 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.180 |
Why?
| | Carotid Arteries | 2 | 2013 | 195 | 0.180 |
Why?
| | Insulinoma | 1 | 2021 | 27 | 0.180 |
Why?
| | Feces | 1 | 2024 | 486 | 0.180 |
Why?
| | Oxygen Consumption | 2 | 2024 | 710 | 0.170 |
Why?
| | Chemokine CXCL10 | 1 | 2021 | 38 | 0.170 |
Why?
| | I-kappa B Kinase | 1 | 2021 | 54 | 0.170 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2021 | 174 | 0.170 |
Why?
| | Endotoxemia | 1 | 2021 | 87 | 0.170 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 66 | 0.170 |
Why?
| | Biosensing Techniques | 2 | 2014 | 133 | 0.170 |
Why?
| | Gene Silencing | 1 | 2021 | 196 | 0.160 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 70 | 0.160 |
Why?
| | Transcriptome | 2 | 2024 | 967 | 0.160 |
Why?
| | Chorioamnionitis | 1 | 2020 | 42 | 0.160 |
Why?
| | Drug Synergism | 1 | 2020 | 368 | 0.160 |
Why?
| | Energy Intake | 1 | 2022 | 506 | 0.160 |
Why?
| | Receptor, Insulin | 2 | 2011 | 100 | 0.160 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2021 | 199 | 0.150 |
Why?
| | Transcription Factors | 1 | 2007 | 1697 | 0.150 |
Why?
| | Extracellular Matrix | 2 | 2013 | 541 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2019 | 177 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 984 | 0.150 |
Why?
| | Vascular Stiffness | 2 | 2013 | 443 | 0.140 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2018 | 23 | 0.140 |
Why?
| | Phosphorylation | 3 | 2019 | 1760 | 0.140 |
Why?
| | Transcription Factor RelA | 1 | 2018 | 85 | 0.140 |
Why?
| | Cell Survival | 1 | 2021 | 1123 | 0.140 |
Why?
| | Neonatology | 1 | 2018 | 28 | 0.140 |
Why?
| | Umbilical Cord | 2 | 2016 | 86 | 0.140 |
Why?
| | Cell Count | 1 | 2018 | 325 | 0.140 |
Why?
| | Infant, Extremely Premature | 1 | 2018 | 66 | 0.130 |
Why?
| | Overnutrition | 1 | 2017 | 30 | 0.130 |
Why?
| | Adipose Tissue | 1 | 2021 | 643 | 0.130 |
Why?
| | Infant Formula | 1 | 2017 | 73 | 0.130 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2024 | 873 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2019 | 202 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 442 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 696 | 0.130 |
Why?
| | Arteries | 1 | 2018 | 263 | 0.130 |
Why?
| | Time Factors | 4 | 2012 | 6851 | 0.130 |
Why?
| | Energy Metabolism | 2 | 2021 | 922 | 0.130 |
Why?
| | Hemodynamics | 1 | 2021 | 1093 | 0.120 |
Why?
| | Calcium | 1 | 2022 | 1180 | 0.120 |
Why?
| | Blotting, Western | 4 | 2019 | 1230 | 0.120 |
Why?
| | Potassium Chloride | 2 | 2014 | 42 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1244 | 0.120 |
Why?
| | Treatment Failure | 1 | 2017 | 351 | 0.120 |
Why?
| | Ultrasonography, Prenatal | 1 | 2018 | 287 | 0.120 |
Why?
| | Linear Models | 1 | 2018 | 852 | 0.120 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2012 | 36 | 0.120 |
Why?
| | Biomedical Research | 1 | 2022 | 694 | 0.120 |
Why?
| | Lower Extremity | 1 | 2019 | 434 | 0.110 |
Why?
| | Cell Division | 1 | 2017 | 794 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1323 | 0.110 |
Why?
| | Parenteral Nutrition | 1 | 2016 | 105 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Nurseries, Hospital | 1 | 2014 | 5 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1092 | 0.110 |
Why?
| | Hydrochlorothiazide | 1 | 2014 | 9 | 0.110 |
Why?
| | Endocrinology | 1 | 2015 | 76 | 0.110 |
Why?
| | Homeostasis | 1 | 2018 | 614 | 0.110 |
Why?
| | Mice, Knockout | 1 | 2021 | 3028 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 46 | 0.100 |
Why?
| | Diuretics | 1 | 2014 | 72 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5798 | 0.100 |
Why?
| | Glucose Transporter Type 3 | 2 | 2024 | 13 | 0.100 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 3392 | 0.100 |
Why?
| | Mice | 5 | 2024 | 17814 | 0.100 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 6 | 0.100 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2018 | 387 | 0.100 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 52 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2016 | 496 | 0.100 |
Why?
| | Pyruvic Acid | 2 | 2024 | 54 | 0.100 |
Why?
| | Cell Size | 1 | 2012 | 89 | 0.100 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.100 |
Why?
| | Premature Birth | 1 | 2016 | 335 | 0.100 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2012 | 15 | 0.100 |
Why?
| | Macrophages | 1 | 2020 | 1543 | 0.090 |
Why?
| | Solutions | 1 | 2012 | 168 | 0.090 |
Why?
| | Umbilical Arteries | 1 | 2012 | 54 | 0.090 |
Why?
| | Heart | 1 | 2016 | 611 | 0.090 |
Why?
| | Hyperplasia | 1 | 2012 | 176 | 0.090 |
Why?
| | Hernia, Diaphragmatic | 1 | 2012 | 66 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2014 | 329 | 0.090 |
Why?
| | Cell Aggregation | 1 | 2011 | 25 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 199 | 0.090 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 197 | 0.090 |
Why?
| | Intestinal Obstruction | 1 | 2012 | 52 | 0.090 |
Why?
| | Mitosis | 1 | 2012 | 192 | 0.090 |
Why?
| | Infant Nutrition Disorders | 1 | 2011 | 10 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 85 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5803 | 0.090 |
Why?
| | Parenteral Nutrition, Total | 1 | 2011 | 26 | 0.090 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 276 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2011 | 171 | 0.090 |
Why?
| | Carbon Dioxide | 2 | 2012 | 241 | 0.080 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 200 | 0.080 |
Why?
| | Animals, Newborn | 2 | 2024 | 859 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 2011 | 230 | 0.080 |
Why?
| | Taurine | 1 | 2011 | 40 | 0.080 |
Why?
| | Algorithms | 3 | 2018 | 1740 | 0.080 |
Why?
| | Intensive Care, Neonatal | 1 | 2010 | 40 | 0.080 |
Why?
| | Blood Vessels | 1 | 2011 | 180 | 0.080 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2011 | 144 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2850 | 0.070 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 43 | 0.070 |
Why?
| | Prevalence | 1 | 2016 | 2727 | 0.070 |
Why?
| | Gene Expression | 2 | 2011 | 1488 | 0.070 |
Why?
| | Glycine | 2 | 2023 | 174 | 0.070 |
Why?
| | Apoptosis | 2 | 2019 | 2546 | 0.070 |
Why?
| | Guidelines as Topic | 1 | 2010 | 272 | 0.070 |
Why?
| | Liver Glycogen | 1 | 2007 | 16 | 0.070 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 25 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 2 | 2020 | 8 | 0.070 |
Why?
| | Cohort Studies | 1 | 2018 | 5697 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 553 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1731 | 0.070 |
Why?
| | Cell Movement | 1 | 2011 | 969 | 0.060 |
Why?
| | Biological Transport | 2 | 2020 | 403 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2007 | 533 | 0.060 |
Why?
| | Lysine | 1 | 2009 | 290 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5520 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2011 | 893 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2007 | 438 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1006 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 888 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1746 | 0.060 |
Why?
| | Adult | 3 | 2023 | 38201 | 0.050 |
Why?
| | Citrate (si)-Synthase | 1 | 2024 | 60 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 103 | 0.050 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 236 | 0.050 |
Why?
| | Risk Factors | 2 | 2016 | 10252 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2011 | 4181 | 0.050 |
Why?
| | Societies, Medical | 2 | 2020 | 839 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Elastin | 2 | 2013 | 79 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 194 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 82 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2022 | 5 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 103 | 0.050 |
Why?
| | Ruminants | 1 | 2022 | 7 | 0.050 |
Why?
| | Serine | 1 | 2023 | 140 | 0.050 |
Why?
| | Glucose Transporter Type 1 | 1 | 2022 | 48 | 0.050 |
Why?
| | Birth Weight | 2 | 2018 | 508 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2022 | 57 | 0.050 |
Why?
| | Blastocyst | 1 | 2021 | 47 | 0.040 |
Why?
| | Phosphates | 1 | 2022 | 180 | 0.040 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 39 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2017 | 10923 | 0.040 |
Why?
| | Placentation | 1 | 2021 | 45 | 0.040 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 36 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2021 | 122 | 0.040 |
Why?
| | Collagen | 2 | 2013 | 459 | 0.040 |
Why?
| | Astrocytoma | 1 | 2001 | 128 | 0.040 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 80 | 0.040 |
Why?
| | Weight Gain | 1 | 2023 | 532 | 0.040 |
Why?
| | Research Personnel | 1 | 2022 | 182 | 0.040 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 42 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2049 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 318 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 209 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 411 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 159 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 626 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 195 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 393 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 152 | 0.040 |
Why?
| | Lung | 1 | 2011 | 4106 | 0.040 |
Why?
| | Body Weight | 2 | 2012 | 992 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2012 | 309 | 0.030 |
Why?
| | Temperature | 1 | 2019 | 658 | 0.030 |
Why?
| | Term Birth | 1 | 2016 | 23 | 0.030 |
Why?
| | Delphi Technique | 1 | 2018 | 289 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2008 | 496 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 85 | 0.030 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2016 | 105 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 31 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 685 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 395 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 824 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2016 | 377 | 0.020 |
Why?
| | Compliance | 1 | 2012 | 50 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 255 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2012 | 166 | 0.020 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 27 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 25 | 0.020 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 25 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 159 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 83 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 385 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 124 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 140 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 199 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 174 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2012 | 330 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 140 | 0.020 |
Why?
| | Stimulation, Chemical | 1 | 2011 | 58 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 414 | 0.020 |
Why?
| | Diseases in Twins | 1 | 2012 | 159 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 921 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2012 | 188 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 701 | 0.020 |
Why?
| | Trans-Activators | 1 | 2012 | 385 | 0.020 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2012 | 201 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 27 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 25 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 33 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 58 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1645 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 509 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 326 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 293 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1567 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 150 | 0.020 |
Why?
| | Child | 2 | 2020 | 21921 | 0.020 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2007 | 16 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4092 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 308 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1739 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2011 | 770 | 0.010 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 415 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 224 | 0.010 |
Why?
| | United States | 1 | 2022 | 14938 | 0.010 |
Why?
| | Hypertension | 1 | 2012 | 1242 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1806 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 32 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5594 | 0.010 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 77 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11158 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 2962 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 3637 | 0.000 |
Why?
|
|
Rozance's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|